Novo Nordisk A/S ADR (NVO)
$123.64
0.27 (0.21%)
NVO Stock Quote Delayed 30 Minutes
Top 5 Stocks for 2024
INSIDE: Investing legend Louis Navellier reveals his Top 5 Stocks for 2024 — FREE!
Download His Free Report Here:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Unlock Louis Navellier's
? Stock Report – FREE:
Is ? a BUY?
Powered by Portfolio Grader
A
B
C
D
F
?
Unlock Louis Navellier's
? Stock Report to Find Out – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Investing legend Louis Navellier rates ? a "?." Unlock his ? Stock Analysis to find out why – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Fundamental Grade
Quantitative Grade
- Sales Growth ?
- Operating Margin Growth ?
- Earnings Growth ?
- Earnings Momentum ?
- Earnings Surprises ?
- Analyst Earnings Revisions ?
- Cash Flow ?
- Return on Equity ?
Previous Close
-
Market Cap
-
PE Ratio
-
EPS
-
Volume (Avg. Vol.)
1.43M
Day's Range
$121.79 - $123.93
52-Week Range
$75.56 - $138.28
Dividend & Yield
$1.77 (1.43%)
NVO Stock Predictions, Articles, and Novo Nordisk A/S ADR News
3 Underappreciated Healthcare Stocks to Buy Now: April 2024
Novo Nordisk (NVO), United Therapeutics (UTHR) and Vertex Pharmaceuticals (VRTX) are three underappreciated healthcare stocks to buy in April.
3 Biopharma Stocks Predicted to Soar in Q2 2024
These biopharma stocks can produce massive returns for Q2 based on new product releases and international treatment approvals.
7 Mega-Cap Stocks That Can Turn $10,000 Into $1 Million
These million dollar mega cap stocks will continue to produce big winners in 2024 and beyond as they continue to rise.
On the Dip: 3 Stocks to Snatch Up Whenever the Market Stumbles
Build a solid portfolio with stocks that shine through all seasons. Here are the stocks to buy the dip each time the market stumbles.
NVO Stock Alert: Novo Nordisk Pops on New Weight-Loss Drug
Novo Nordisk stock is gaining on Thursday as NVO investors react to positive news from its new weight loss drug clinical trial.
Why Is Vivani Medical (VANI) Stock Up 300% Today?
With Vivani Medical introducing pre-clinical efficacy data for its weight-loss solution, VANI stock soared on the broader implications.
